According to filings with the U.S. Securities and Exchange Commission, Bunkerhill Health has raised $55 Million in new Series B funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

Investors in the company’s current round of funding include: Khosla Ventures, Sequoia Capital, Felicis, Optum Ventures, and Y Combinator

About Bunkerhill Health
Bunkerhill Health builds Carebricks, an agentic AI platform that gives health systems a single foundation to deploy AI agents across the full scope of how they operate. The company partners with some of the most respected health systems in the country, including Cleveland Clinic, the University of Texas Medical Branch, and Intermountain Health, empowering them to turn their ideas into reality with unmatched speed and flexibility.

To learn more, visit https://www.bunkerhillhealth.com/
Linkedin: https://www.linkedin.com/company/bunkerhill-health/

Contact:
Nishith Khandwala, Chief Executive Officer
https://www.linkedin.com/in/nishith-khandwala-16b27227/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.